-+ 0.00%
-+ 0.00%
-+ 0.00%

Rodman & Renshaw initiates Quantum BioPharma coverage with buy rating, US$ 8 target

PUBT·09/17/2026 12:01:37
Listen to the news
Rodman & Renshaw initiates Quantum BioPharma coverage with buy rating, US$ 8 target
  • Rodman & Renshaw initiated coverage of Quantum BioPharma with a Buy rating.
  • The firm set a US$ 8 price target.
  • Coverage was described as unpaid, with no consideration provided for the report.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum Biopharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609170800PRIMZONECNPR____9828644) on September 17, 2026, and is solely responsible for the information contained therein.